Close
Close

Celldex Therapeutics - Recurrent GBM

Partner

Not provided

Rare Disease

Recurrent GBM

Sponsor

Celldex Therapeutics

Access Program Information

Celldex endeavors to make investigational products available to patients with life-threatening diseases who have exhausted other treatment options and where there is a reasonable expectation of benefit over risk. Requests for expanded access to rindopepimut in patients with EGFRvlll expressing recurrent glioblastoma will be considered.

Contact

Contact: Celldex Therapeutics ((203) 483-3500)

Locations

Free Newsletter